StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma operating margin

Operating margin is operating income as a percentage of revenue.

Regen BioPharma's operating margin for the twelve months ending Jun 30, 2026 was -339.8%. For fiscal 2025 it was -143.1%, against -176.4% the year before. The highest annual figure on record is -143.1% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 2025-143.1%+33.3
FY2024Sep 30, 2024-176.4%+114.0
FY2023Sep 30, 2023-290.4%−19.8
FY2022Sep 30, 2022-270.6%+57.5
FY2021Sep 30, 2021-328.1%−137.8
FY2020Sep 30, 2020-190.3%+497.7
FY2019Sep 30, 2019-688.0%+737.8
FY2018Sep 30, 2018-1425.8%+856.8
FY2017Sep 30, 2017-2282.6%+674.3
FY2016Sep 30, 2016-2957.0%−1926.1
FY2015Sep 30, 2015-1030.9%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jun 30, 202641.5%+110.5
Q2 FY2026CQ1 2026Mar 31, 2026-260.2%−68.3
Q1 FY2026CQ4 2025Dec 31, 2025-933.9%−830.0
Q4 FY2025CQ3 2025Sep 30, 2025-207.3%−63.4
Q3 FY2025CQ2 2025Jun 30, 2025-69.0%+113.8
Q2 FY2025CQ1 2025Mar 31, 2025-191.9%−20.8
Q1 FY2025CQ4 2024Dec 31, 2024-103.9%+104.0
Q4 FY2024CQ3 2024Sep 30, 2024-143.9%−44.3
Q3 FY2024CQ2 2024Jun 30, 2024-182.8%−38.6
Q2 FY2024CQ1 2024Mar 31, 2024-171.1%+78.1
Q1 FY2024CQ4 2023Dec 31, 2023-207.9%+1258.2
Q4 FY2023CQ3 2023Sep 30, 2023-99.5%+209.5
Q3 FY2023CQ2 2023Jun 30, 2023-144.2%+44.1
Q2 FY2023CQ1 2023Mar 31, 2023-249.2%−2.0
Q1 FY2023CQ4 2022Dec 31, 2022-1466.1%−1129.7
Q4 FY2022CQ3 2022Sep 30, 2022-309.0%+87.4
Q3 FY2022CQ2 2022Jun 30, 2022-188.3%−42.8
Q2 FY2022CQ1 2022Mar 31, 2022-247.2%−199.9
Q1 FY2022CQ4 2021Dec 31, 2021-336.4%−269.0
Q4 FY2021CQ3 2021Sep 30, 2021-396.5%−328.3
Q3 FY2021CQ2 2021Jun 30, 2021-145.5%−85.9
Q2 FY2021CQ1 2021Mar 31, 2021-47.3%+96.1
Q1 FY2021CQ4 2020Dec 31, 2020-67.4%+423.9
Q4 FY2020CQ3 2020Sep 30, 2020-68.2%+615.1
Q3 FY2020CQ2 2020Jun 30, 2020-59.6%+442.6
Q2 FY2020CQ1 2020Mar 31, 2020-143.4%+698.1
Q1 FY2020CQ4 2019Dec 31, 2019-491.3%+233.7
Q4 FY2019CQ3 2019Sep 30, 2019-683.3%−558.0
Q3 FY2019CQ2 2019Jun 30, 2019-502.2%+0.6
Q2 FY2019CQ1 2019Mar 31, 2019-841.5%−164.7
Q1 FY2019CQ4 2018Dec 31, 2018-725.0%–
Q3 FY2018CQ2 2018Jun 30, 2018-125.2%–
Q3 FY2017CQ2 2017Jun 30, 2017-502.8%–
Q4 FY2016CQ3 2016Sep 30, 2016-676.9%–

More Regen BioPharma figures

See a number that looks wrong?